Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Vancomycin-induced red man syndrome in pediatric oncology: still an issue?

Literature DB >> 22161495

Vancomycin-induced red man syndrome in pediatric oncology: still an issue?

Tiene Bauters¹, Barbara Claus, Petra Schelstraete, Hugo Robays, Yves Benoit, Catharina Dhooge.

Abstract

Red man syndrome is a rare but possibly serious adverse reaction during treatment with intravenous vancomycin. It is extremely important that pediatricians, especially in oncology, recognize this reaction and treat it appropriately. Following two case-reports from a pediatric oncology setting, a series of practical recommendations to prevent or handle red man syndrome are described.

Entities: Chemical Disease

Mesh：

Substances：

Year: 2011 PMID： 22161495 DOI： 10.1007/s11096-011-9593-z

Source DB: PubMed Journal: Int J Clin Pharm

15 in total

1. A new system for grading recommendations in evidence based guidelines.

Authors: R Harbour; J Miller
Journal: BMJ Date: 2001-08-11

2. Red man syndrome.

Authors: R E Polk
Journal: Ann Pharmacother Date: 1998 Jul-Aug Impact factor: 3.154

3. Vancomycin and the red-man syndrome: pharmacodynamics of histamine release.

Authors: R E Polk; D P Healy; L B Schwartz; D T Rock; M L Garson; K Roller
Journal: J Infect Dis Date: 1988-03 Impact factor: 5.226

Review 4. Desensitization protocols for vancomycin hypersensitivity.

Authors: L D Wazny; B Daghigh
Journal: Ann Pharmacother Date: 2001-11 Impact factor: 3.154

5. Comparison of vancomycin- and teicoplanin-induced histamine release and "red man syndrome".

Authors: J Sahai; D P Healy; M J Shelton; J S Miller; S J Ruberg; R Polk
Journal: Antimicrob Agents Chemother Date: 1990-05 Impact factor: 5.191

6. Continuous versus intermittent infusion of vancomycin in severe Staphylococcal infections: prospective multicenter randomized study.

Authors: M Wysocki; F Delatour; F Faurisson; A Rauss; Y Pean; B Misset; F Thomas; J F Timsit; T Similowski; H Mentec; L Mier; D Dreyfuss
Journal: Antimicrob Agents Chemother Date: 2001-09 Impact factor: 5.191

3. The impact of a pilot continuing professional development module on hospital pharmacists' preparedness to provide contemporary advice on the clinical use of vancomycin.

Authors: Cameron J Phillips; Alice J Wisdom; Vaughn S Eaton; Richard J Woodman; Ross A McKinnon
Journal: Springerplus Date: 2016-03-15

3 in total

Vancomycin-induced red man syndrome in pediatric oncology: still an issue?

1. A new system for grading recommendations in evidence based guidelines.

2. Red man syndrome.

3. Vancomycin and the red-man syndrome: pharmacodynamics of histamine release.

Review 4. Desensitization protocols for vancomycin hypersensitivity.

5. Comparison of vancomycin- and teicoplanin-induced histamine release and "red man syndrome".

6. Continuous versus intermittent infusion of vancomycin in severe Staphylococcal infections: prospective multicenter randomized study.

7. Compatibility of commonly used bone marrow transplant drugs during Y-site delivery.

8. Oral antihistamines reduce the side effects from rapid vancomycin infusion.

9. High dose vancomycin for osteomyelitis: continuous vs. intermittent infusion.

10. Red man syndrome.

1. DRUG-RELATED PROBLEMS IN CARDIAC NEONATES UNDER INTENSIVE CARE.

2. Adverse Drug Reactions Spontaneously Reported at a Tertiary Care Hospital and Preventable Measures Implemented.

3. The impact of a pilot continuing professional development module on hospital pharmacists' preparedness to provide contemporary advice on the clinical use of vancomycin.